Author:
Brown Li-An,Stone Neil,Coughlan Charles
Reference66 articles.
1. Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis;Abruzzo;Antimicrobial Agents and Chemotherapy,1995
2. Novel orally active inhibitors of β-1,3-glucan synthesis derived from enfumafungin;Apgar;Bioorganic & Medicinal Chemistry Letters,2015
3. Ibrexafungerp: An orally active β-1,3-glucan synthesis inhibitor;Apgar;Bioorganic & Medicinal Chemistry Letters,2021
4. In vitro activity of ibrexafungerp (SCY-078) against Candida auris isolates as determined by EUCAST methodology and comparison with activity against C. albicans and C. glabrata and with the activities of six comparator agents;Arendrup;Antimicrobial Agents and Chemotherapy,2020